BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

977 related articles for article (PubMed ID: 23097559)

  • 1. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
    Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
    Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
    Deng M; Ye Q; Qin Z; Zheng Y; He W; Tang H; Zhou Y; Xiong W; Zhou M; Li X; Yan Q; Ma J; Li G
    Tumour Biol; 2013 Jun; 34(3):1793-800. PubMed ID: 23479198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells.
    Sun XJ; Liu H; Zhang P; Zhang XD; Jiang ZW; Jiang CC
    Asian Pac J Cancer Prev; 2013; 14(9):5533-7. PubMed ID: 24175854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA expression profiling of nasopharyngeal carcinoma.
    Li T; Chen JX; Fu XP; Yang S; Zhang Z; Chen KhH; Li Y
    Oncol Rep; 2011 May; 25(5):1353-63. PubMed ID: 21373758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
    Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
    Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
    Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
    Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miR-18a-5p promotes EMT and metastasis of NPC cells via targeting BTG3 and activating the Wnt/β-catenin signaling pathway.
    Zhong Q; Nie Q; Wu R; Huang Y
    Cell Cycle; 2023 Jul; 22(13):1544-1562. PubMed ID: 37287276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
    Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
    BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression.
    Qiu F; Sun R; Deng N; Guo T; Cao Y; Yu Y; Wang X; Zou B; Zhang S; Jing T; Ling T; Xie J; Zhang Q
    PLoS One; 2015; 10(3):e0120969. PubMed ID: 25786138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the roles of miR-372 in cell proliferation and apoptosis of nasopharyngeal carcinoma TW01 cells.
    Tan JK; Tan EL; Gan SY
    Exp Oncol; 2014 Sep; 36(3):170-3. PubMed ID: 25265349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.
    Tang JF; Yu ZH; Liu T; Lin ZY; Wang YH; Yang LW; He HJ; Cao J; Huang HL; Liu G
    Asian Pac J Cancer Prev; 2014; 15(18):7575-81. PubMed ID: 25292031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
    Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
    Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma.
    Mai S; Xiao R; Shi L; Zhou X; Yang T; Zhang M; Weng N; Zhao X; Wang R; Liu J; Sun R; Qin H; Wang H
    Cell Death Dis; 2019 Oct; 10(11):819. PubMed ID: 31659158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.